January 12, 2020 at 3:08 PM CST - Updated January 12 at 3:08 PM A Gray Media Group, Inc. Station - © 2002-2020 Gray Television, Inc. Kevin Foster is a Digital Content Producer for WAFB. Get the news you need delivered right to you. Recalls; published on 01/28/2020 Taro Pharmaceuticals recalls Lamotrigine tablets The product was cross-contaminated with Enalapril Maleate. Each bottle is labeled to indicate the name of the product, Lamotrigine Tablets USP, 100 mg, and the NDC #51672-4131-1. Our content is intended to be used for general information purposes only. The drug is associated with risk of birth defects in a developing fetus, and poses a risk specifically to small children and pregnant women. Enalapril Maleate is a drug substance indicated for hypertension and congestive heart failure. The contents of this site may not be republished, reprinted, rewritten or recirculated without written permission.Coronavirus update: Another antibody drug shows promise, Yelp cites the rising toll on businessesOnly 2 percent of Red Cross blood donors have coronavirus antibodies, study suggestsTeachers' stress could have a negative impact on students' classroom behavior, study findsSouthwest Airlines updates COVID-19 policies for both passengers and employeesGetting more sleep helps consumers better handle positive and negative events, study findsEli Lilly claims its antibody drug significantly reduced hospitalization rate in COVID-19 patients The recalled product is packaged in white plastic bottles with screw cap closure, and each bottle contains 100 tablets. Enjoy reading our tips and recommendations.Sign up to receive our free weekly newsletter. It is also associated with risk of birth defects in a developing fetus.No product complaints or adverse events have been reported to date.The following product, packaged in white plastic bottles with screw cap closure containing 100 tablets, is being recalled:The recalled product was shipped to wholesale customers in the US market from August 23 – 30, 2019. who may may have further distributed them to retail pharmacies for prescription dispensing to patientsPatients who have the recalled product should stop using and return it to the pharmacy that dispensed it.Consumers with questions may contact Taro at (866) 923-4914 Monday through Friday from 7:00 AM – 7:00 PM (CT), or by e-mail at [email protected]. Unsubscribe easily.ConsumerAffairs is not a government agency. Lamotrigine oral tablet is a prescription medication used to treat seizures in people with epilepsy and bipolar disorder. On January 10, 2020, the U.S. Food and Drug Administration (FDA) published a company alert about a voluntary recall of lamotrigine 100 mg tablets from Taro Pharmaceuticals.. Lamotrigine 100 mg tablets from lot # 331771 are being recalled due to possible contamination with another medicine. Taro announces Lamotrigine recall NCPA January 12, 2020 This single lot of Lamotrigine 100 mg Tablets Lot #331771 (expiration date June 2021) was found to have been cross contaminated with a small amount of another drug substance (Enalapril Maleate) used to manufacture another product at the same facility. by Kristen Monaco, Staff Writer, MedPage Today January 15, 2020 Taro Pharmaceuticals U.S.A., Inc. Issues Voluntary Nationwide Recall of Lamotrigine Tablets USP, 100 mg, 100 Count Bottles (NDC 51672-4131-1) Lot # … It is very important to do your own analysis before making any investment based on your own personal circumstances and consult with your own investment, financial, tax and legal advisers.Copyright © 2020 Consumers Unified LLC. The product has an expiration date of June 2021.The recalled product was distributed around the U.S. between August 23 and August 30, 2019.Consumers with questions regarding this recall can contact Taro by calling 1-866-923-4914.
The product has an expiration date of June 2021.
The U.S. Food and Drug Administration issued an alert that lot number 331771 of Lamotrigine 100 mg Tablets was found to have been cross-contaminated with a small amount of Enalapril Maleate.
A Washington, D.C., reporter for more than 30 years, Jim Limbach covers the federal agencies for ConsumerAffairs. Unsubscribe at any time.We’ll start sending you the news you need delivered straight to you. January 10, 2020 - Taro Pharmaceuticals announced a voluntary, consumer-level recall of lamotrigine tablets because one lot was found to have been cross-contaminated with a small amount of another drug substance, enalapril maleate, used to manufacture another product at the same facility. Previously, he was a reporter and news anchor for Associated Press Broadcast Services, where he covered business and consumer news as well as space shots and other major spot news events. He writes local, national, breaking and viral news, and copy edits written reports, contributing to digital platforms.A woman in Denham Springs says she has just two weeks to pay back nearly $11,000 in overpaid unemployment benefits.